Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02BNC
|
|||
| Former ID |
DNC013410
|
|||
| Drug Name |
3-(1,8-naphthyridin-2-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL235397; 3-(1,8-naphthyridin-2-yl)benzonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H9N3
|
|||
| Canonical SMILES |
C1=CC(=CC(=C1)C2=NC3=C(C=CC=N3)C=C2)C#N
|
|||
| InChI |
1S/C15H9N3/c16-10-11-3-1-4-13(9-11)14-7-6-12-5-2-8-17-15(12)18-14/h1-9H
|
|||
| InChIKey |
ANJYTIPEHJCPPM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.